1. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial. Issue 12 (December 2016) Authors: Al-Batran, Salah-Eddin; Hofheinz, Ralf D; Pauligk, Claudia; Kopp, Hans-Georg; Haag, Georg Martin; Luley, Kim Barbara; Meiler, Johannes; Homann, Nils; Lorenzen, Sylvie; Schmalenberg, Harald; Probst, Stephan; Koenigsmann, Michael; Egger, Matthias; Prasnikar, Nicole; Caca, Karel; Trojan, Jörg; Marte... Journal: Lancet oncology Issue: Volume 17:Issue 12(2016:Dec.) Page Start: 1697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase‐II study—The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO‐0510. Issue 6 (15th November 2021) Authors: Högner, Anica; Al‐Batran, Salah‐Eddin; Siveke, Jens T.; Lorenz, Mario; Bartels, Prisca; Breithaupt, Kirstin; Malfertheiner, Peter; Homann, Nils; Stein, Alexander; Gläser, Dietrich; Tamm, Ingo; Hinke, Axel; Vogel, Arndt; Thuss‐Patience, Peter Journal: International journal of cancer Issue: Volume 150:Issue 6(2022) Page Start: 1007 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Issue 10184 (11th May 2019) Authors: Al-Batran, Salah-Eddin; Homann, Nils; Pauligk, Claudia; Goetze, Thorsten O; Meiler, Johannes; Kasper, Stefan; Kopp, Hans-Georg; Mayer, Frank; Haag, Georg Martin; Luley, Kim; Lindig, Udo; Schmiegel, Wolff; Pohl, Michael; Stoehlmacher, Jan; Folprecht, Gunnar; Probst, Stephan; Prasnikar, Nicole; Fis... Journal: Lancet Issue: Volume 393:Issue 10184(2019) Page Start: 1948 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen (RADPAC). Issue 9 (7th May 2020) Authors: Lorenzen, Sylvie; Knorrenschild, Jorge Riera; Pauligk, Claudia; Hegewisch‐Becker, Susanna; Seraphin, Jörg; Thuss‐Patience, Peter; Kopp, Hans‐Georg; Dechow, Tobias; Vogel, Arndt; Luley, Kim Barbara; Pink, Daniel; Stahl, Michael; Kullmann, Frank; Hebart, Holger; Siveke, Jens; Egger, Matthias; Homan... Journal: International journal of cancer Issue: Volume 147:Issue 9(2020) Page Start: 2493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. Issue 6 (23rd October 2020) Authors: Al‐Batran, Salah‐Eddin; Hofheinz, Ralf‐Dieter; Reichart, Alexander; Pauligk, Claudia; Schönherr, Caroline; Schlag, Rudolf; Siegler, Gabriele; Dörfel, Steffen; Koenigsmann, Michael; Zahn, Mark‐Oliver; Schubert, Jörg; Aldaoud, Ali; Höffkes, Heinz‐Gert; Schulz, Holger; Hahn, Lars; Uhlig, Jens; Blau,... Journal: International journal of cancer Issue: Volume 148:Issue 6(2021) Page Start: 1478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. Issue 6 (23rd October 2020) Authors: Al‐Batran, Salah‐Eddin; Hofheinz, Ralf‐Dieter; Reichart, Alexander; Pauligk, Claudia; Schönherr, Caroline; Schlag, Rudolf; Siegler, Gabriele; Dörfel, Steffen; Koenigsmann, Michael; Zahn, Mark‐Oliver; Schubert, Jörg; Aldaoud, Ali; Höffkes, Heinz‐Gert; Schulz, Holger; Hahn, Lars; Uhlig, Jens; Blau,... Journal: International journal of cancer Issue: Volume 148:Issue 6(2021) Page Start: 1478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group. Issue 6 (29th May 2021) Authors: Hofheinz, Ralf‐Dieter; Hegewisch‐Becker, Susanne; Kunzmann, Volker; Thuss‐Patience, Peter; Fuchs, Martin; Homann, Nils; Graeven, Ullrich; Schulte, Nadine; Merx, Kirsten; Pohl, Michael; Held, Swantje; Keller, Ralph; Tannapfel, Andrea; Al‐Batran, Salah‐Eddin Journal: International journal of cancer Issue: Volume 149:Issue 6(2021) Page Start: 1322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗